Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 12th:
Capital City Bank Group, Inc. (CCBG - Free Report) : This financial holding company for Capital City Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Capital City Bank Group Price and Consensus
Capital City’ shares gained 11.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of B.
Capital City Bank Group Price
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.4% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore’s shares gained 12.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Immunocore Holdings PLC Sponsored ADR Price
F-star Therapeutics, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Fstar Therapeutics, Inc. Price and Consensus
F-star’s shares gained 86.8% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Fstar Therapeutics, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 12th:
Capital City Bank Group, Inc. (CCBG - Free Report) : This financial holding company for Capital City Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Capital City Bank Group Price and Consensus
Capital City’ shares gained 11.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of B.
Capital City Bank Group Price
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.4% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore’s shares gained 12.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Immunocore Holdings PLC Sponsored ADR Price
F-star Therapeutics, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Fstar Therapeutics, Inc. Price and Consensus
F-star’s shares gained 86.8% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Fstar Therapeutics, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CCBG - FREE
Get the latest research report on IMCR - FREE